A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
The objective of this study is to evaluate the safety and image quality of the investigational dye, MB-102, compared to the control dye (fluorescein sodium) in healthy and diseased eyes using fluorescent angiography for retinal vascular disease diagnosis and monitoring.
• Age \> 18 years - male or female
‣ Eligible female non-pregnant participants who are either not of child-bearing potential or willing to utilize adequate contraception during the trial
⁃ Males must be willing to practice abstinence or utilize adequate contraception from MB-102 dosing day to at least 7 days post dose
• Participants willing to comply with study requirements
• Participants who have signed an informed consent form
∙ At least 5 participants will have a current history of retinal or choroidal vascular diseases.